Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children

Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study

(2022) Camelia Savulescu et al.   VACCINE

Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes

(2021) Zahin Amin-Chowdhury et al.   VACCINE

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance

(2021) Chiara Scelfo et al.   Vaccines

Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011–2018

(2021) Alyssa R. Golden et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006–2019. Temporal progression of serotypes distribution and antibiotic resistance

(2021) Jonathan Zintgraff et al.   VACCINE

Age-Dependent Serotype-Associated Case-Fatality Rate in Invasive Pneumococcal Disease in the Autonomous Community of Madrid between 2007 and 2020

(2021) Sara De Miguel et al.   Microorganisms

Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age

(2021) Matt D. Wasserman et al.   Infectious Diseases and Therapy

Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001–2016

(2020) Tolulope A. Adebanjo et al.   PEDIATRICS

Clinical Relevance and Molecular Pathogenesis of the Emerging Serotypes 22F and 33F of Streptococcus pneumoniae in Spain

(2020) Julio Sempere et al.   Frontiers in Microbiology

Characteristics of Serotype 3 Invasive Pneumococcal Disease before and after Universal Childhood Immunization with PCV13 in Massachusetts

(2020) Rotem Lapidot et al.   Pathogens

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

(2020) Heather L. Platt et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Nationwide trends of invasive pneumococcal disease in Spain (2009-2019) in children and adults during the pneumococcal conjugate vaccine era

(2020) Sara de Miguel et al.   CLINICAL INFECTIOUS DISEASES

Enhanced antipneumococcal antibody electrochemiluminescence assay: validation and bridging to the WHO reference ELISA

(2020) Katrina M Nolan et al.   Bioanalysis

Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in children in the United States

(2020) Tianyan Hu et al.   JOURNAL OF MEDICAL ECONOMICS

Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015

(2019) Srinivas Acharya Nanduri et al.   JAMA Pediatrics

A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

(2019) R. Rupp et al.   Human Vaccines & Immunotherapeutics

Multistate population and whole genome sequence based strain surveillance of invasive pneumococci recovered in the United States during 2017

(2019) Jasmine Varghese et al.   CLINICAL MICROBIOLOGY AND INFECTION

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

(2018) Shamez N Ladhani et al.   LANCET INFECTIOUS DISEASES

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

(2018) David Greenberg et al.   VACCINE

Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US Infants

(2017) Stanley L. Block et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis

(2017) Evelyn Balsells et al.   PLoS One

Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study

(2016) Matthew R Moore et al.   Lancet Respiratory Medicine

Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany

(2016) Mark van der Linden et al.   PLoS One

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

(2015) Matthew R Moore et al.   LANCET INFECTIOUS DISEASES

Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine

(2015) Ajoke Sobanjo-ter Meulen et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

(2014) Nick J Andrews et al.   LANCET INFECTIOUS DISEASES

Placebo use in vaccine trials: Recommendations of a WHO expert panel

(2014) Annette Rid et al.   VACCINE

Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines

(2012) T. Q. Tan   CLINICAL MICROBIOLOGY REVIEWS

Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period

(2012) Gaston De Serres et al.   VACCINE

Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease

(2010) Inci Yildirim et al.   VACCINE

Optimization and Validation of a Multiplex, Electrochemiluminescence-Based Detection Assay for the Quantitation of Immunoglobulin G Serotype-Specific Antipneumococcal Antibodies in Human Serum

(2009) R. D. Marchese et al.   Clinical and Vaccine Immunology

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

(2009) Katherine L O'Brien et al.   LANCET